Search

Jeffrey E. Russel

Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809
Total Applications
3437
Issued Applications
2371
Pending Applications
237
Abandoned Applications
837

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6445962 [patent_doc_number] => 20100279923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'THERAPEUTIC APPLICATION OF KAZAL-TYPE SERINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/526758 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12088 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279923.pdf [firstpage_image] =>[orig_patent_app_number] => 12526758 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/526758
Therapeutic application of Kazal-type serine protease inhibitors Feb 10, 2008 Issued
Array ( [id] => 4786133 [patent_doc_number] => 20080139462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING LANTIBIOTIC CONTAINING COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/026358 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16103 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139462.pdf [firstpage_image] =>[orig_patent_app_number] => 12026358 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/026358
TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING LANTIBIOTIC CONTAINING COMPOSITIONS Feb 4, 2008 Abandoned
Array ( [id] => 5546747 [patent_doc_number] => 20090156624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Methionine aminopeptidase-2 inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/011685 [patent_app_country] => US [patent_app_date] => 2008-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17791 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156624.pdf [firstpage_image] =>[orig_patent_app_number] => 12011685 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/011685
Methionine aminopeptidase-2 inhibitors and methods of use thereof Jan 28, 2008 Abandoned
Array ( [id] => 4664341 [patent_doc_number] => 20080255248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Prodrug compounds with isoleucine' [patent_app_type] => utility [patent_app_number] => 12/009031 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22596 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255248.pdf [firstpage_image] =>[orig_patent_app_number] => 12009031 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/009031
Prodrug compounds with isoleucine Jan 15, 2008 Issued
Array ( [id] => 4904502 [patent_doc_number] => 20080113916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Povidone-Containing Carriers for Polypeptide Growth Factors' [patent_app_type] => utility [patent_app_number] => 12/013517 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7084 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113916.pdf [firstpage_image] =>[orig_patent_app_number] => 12013517 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/013517
Povidone-Containing Carriers for Polypeptide Growth Factors Jan 13, 2008 Abandoned
Array ( [id] => 12673 [patent_doc_number] => 07807141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Peptide-based oral care surface reagents for personal care' [patent_app_type] => utility [patent_app_number] => 11/971975 [patent_app_country] => US [patent_app_date] => 2008-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29865 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807141.pdf [firstpage_image] =>[orig_patent_app_number] => 11971975 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/971975
Peptide-based oral care surface reagents for personal care Jan 9, 2008 Issued
Array ( [id] => 4664145 [patent_doc_number] => 20080255052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Immunologic regulation by theta defensins' [patent_app_type] => utility [patent_app_number] => 12/006991 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14203 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255052.pdf [firstpage_image] =>[orig_patent_app_number] => 12006991 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/006991
Immunologic regulation by theta defensins Jan 6, 2008 Abandoned
Array ( [id] => 4965757 [patent_doc_number] => 20080108577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Tissue adhering compositions' [patent_app_type] => utility [patent_app_number] => 12/004964 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8325 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108577.pdf [firstpage_image] =>[orig_patent_app_number] => 12004964 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/004964
Tissue adhering compositions Dec 20, 2007 Issued
Array ( [id] => 6443607 [patent_doc_number] => 20100144596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/448358 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5974 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144596.pdf [firstpage_image] =>[orig_patent_app_number] => 12448358 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/448358
An Apo-Ferredoxin Preparation, A Process For Producing Same And Uses Thereof Dec 17, 2007 Abandoned
Array ( [id] => 4571 [patent_doc_number] => 07811995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Therapeutic and diagnostic peptides' [patent_app_type] => utility [patent_app_number] => 11/955226 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 8510 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811995.pdf [firstpage_image] =>[orig_patent_app_number] => 11955226 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/955226
Therapeutic and diagnostic peptides Dec 11, 2007 Issued
Array ( [id] => 4739428 [patent_doc_number] => 20080233081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'PRO-ANGIOGENIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/955143 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6700 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233081.pdf [firstpage_image] =>[orig_patent_app_number] => 11955143 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/955143
Pro-angiogenic peptides Dec 11, 2007 Issued
Array ( [id] => 4746167 [patent_doc_number] => 20080090769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'TREATMENT OF PSORIASIS THROUGH DOWN-REGULATION OF THE EGF-RECEPTOR WITH TOPICALLY APPLIED EGF' [patent_app_type] => utility [patent_app_number] => 11/954006 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 588 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090769.pdf [firstpage_image] =>[orig_patent_app_number] => 11954006 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/954006
TREATMENT OF PSORIASIS THROUGH DOWN-REGULATION OF THE EGF-RECEPTOR WITH TOPICALLY APPLIED EGF Dec 10, 2007 Abandoned
Array ( [id] => 4753169 [patent_doc_number] => 20080161244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes' [patent_app_type] => utility [patent_app_number] => 12/001449 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 7143 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161244.pdf [firstpage_image] =>[orig_patent_app_number] => 12001449 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/001449
Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes Dec 10, 2007 Issued
Array ( [id] => 4965756 [patent_doc_number] => 20080108576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Novel cytostatic conjugates with integrin ligands' [patent_app_type] => utility [patent_app_number] => 11/999445 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20154 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108576.pdf [firstpage_image] =>[orig_patent_app_number] => 11999445 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/999445
Novel cytostatic conjugates with integrin ligands Dec 3, 2007 Abandoned
Array ( [id] => 4792665 [patent_doc_number] => 20080293639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES CHARACTERIZED BY AN INFLAMMATORY RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/950315 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 48266 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293639.pdf [firstpage_image] =>[orig_patent_app_number] => 11950315 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/950315
PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES CHARACTERIZED BY AN INFLAMMATORY RESPONSE Dec 3, 2007 Abandoned
Array ( [id] => 8621635 [patent_doc_number] => 08354549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Method for preparing a polymer conjugate' [patent_app_type] => utility [patent_app_number] => 12/515736 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10091 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12515736 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/515736
Method for preparing a polymer conjugate Nov 29, 2007 Issued
Array ( [id] => 52731 [patent_doc_number] => 07771962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'CD10-activated prodrug compounds' [patent_app_type] => utility [patent_app_number] => 11/986096 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 38102 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771962.pdf [firstpage_image] =>[orig_patent_app_number] => 11986096 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986096
CD10-activated prodrug compounds Nov 19, 2007 Issued
Array ( [id] => 4808121 [patent_doc_number] => 20080171699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Novel cyclic peptides' [patent_app_type] => utility [patent_app_number] => 11/986078 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18772 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171699.pdf [firstpage_image] =>[orig_patent_app_number] => 11986078 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986078
Cyclic peptides Nov 18, 2007 Issued
Array ( [id] => 7987991 [patent_doc_number] => 08076290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Stabilizing alkylglycoside compositions and methods thereof' [patent_app_type] => utility [patent_app_number] => 11/937966 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19580 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076290.pdf [firstpage_image] =>[orig_patent_app_number] => 11937966 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/937966
Stabilizing alkylglycoside compositions and methods thereof Nov 8, 2007 Issued
Array ( [id] => 5368669 [patent_doc_number] => 20090306228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 11/933846 [patent_app_country] => US [patent_app_date] => 2007-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 91204 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306228.pdf [firstpage_image] =>[orig_patent_app_number] => 11933846 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/933846
ACTIVE AGENT DELIVERY SYSTEMS AND METHODS FOR PROTECTING AND ADMINISTERING ACTIVE AGENTS Oct 31, 2007 Abandoned
Menu